Semler Scientific, Inc. (SMLR)
NASDAQ$36.86
Market Cap
$353.73M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
111 of 917
Rank in Industry
8 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
SMLR Insider Trading Activity
SMLR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $1,896,500 | 1 | 17 |
Sells | $8,269,694 | 5 | 83 |
Related Transactions
| SEMLER ERIC | director | 1 | $1.9M | 0 | $0 | $1.9M |
| Murphy-Chutorian Douglas | CEO | 0 | $0 | 5 | $8.27M | $-8.27M |
About Semler Scientific, Inc.
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery …
Insider Activity of Semler Scientific, Inc.
Over the last 12 months, insiders at Semler Scientific, Inc. have bought $1.9M and sold $8.27M worth of Semler Scientific, Inc. stock.
On average, over the past 5 years, insiders at Semler Scientific, Inc. have bought $2.02M and sold $5.75M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SEMLER ERIC (director) — $1.9M.
The last purchase of 50,000 shares for transaction amount of $1.9M was made by SEMLER ERIC (director) on 2024‑11‑07.
List of Insider Buy and Sell Transactions, Semler Scientific, Inc.
| 2024-12-11 | Sale | Murphy-Chutorian Douglas | CEO | 25,000 0.2963% | $62.24 | $1.56M | -21.18% | |
| 2024-12-10 | Sale | Murphy-Chutorian Douglas | CEO | 75,000 0.9142% | $60.12 | $4.51M | -14.59% | |
| 2024-11-07 | Sale | Murphy-Chutorian Douglas | CEO | 50,000 0.72% | $37.93 | $1.9M | +36.99% | |
| 2024-11-07 | SEMLER ERIC | director | 50,000 0.72% | $37.93 | $1.9M | +36.99% | ||
| 2024-08-29 | Sale | Murphy-Chutorian Douglas | CEO | 10,101 0.1497% | $28.34 | $286,302 | +56.78% | |
| 2024-08-28 | Sale | Murphy-Chutorian Douglas | CEO | 780 0.0113% | $28.32 | $22,087 | +53.91% | |
| 2023-09-13 | SEMLER ERIC | director | 26,868 0.3916% | $28.11 | $755,259 | +11.36% | ||
| 2023-09-12 | SEMLER ERIC | director | 25,903 0.372% | $27.70 | $717,513 | +10.09% | ||
| 2023-09-11 | SEMLER ERIC | director | 25,000 0.3631% | $26.98 | $674,500 | +14.28% | ||
| 2022-02-28 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0294% | $72.65 | $145,291 | -50.36% | |
| 2022-02-22 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0297% | $70.22 | $140,430 | -47.49% | |
| 2022-02-15 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0291% | $76.04 | $152,079 | -51.87% | |
| 2022-02-07 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0296% | $78.73 | $157,451 | -52.22% | |
| 2022-02-01 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0288% | $76.53 | $153,056 | -51.47% | |
| 2022-01-24 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0284% | $72.35 | $144,696 | -48.78% | |
| 2022-01-18 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 2,000 0.0294% | $76.69 | $153,374 | -49.50% | |
| 2021-10-25 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 1,250 0.0185% | $144.03 | $180,036 | -68.58% | |
| 2021-10-18 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 1,250 0.0184% | $137.36 | $171,704 | -66.92% | |
| 2021-10-11 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 1,250 0.0186% | $129.01 | $161,258 | -63.74% | |
| 2021-10-04 | Sale | Murphy-Chutorian Douglas | Chief Executive Officer | 1,250 0.0185% | $127.28 | $159,099 | -62.85% |
Total: 112
*Gray background shows transactions not older than one year
Insider Historical Profitability
1.64%
| SEMLER ERIC | director | 621721 6.4786% | $22.92M | 5 | 0 | <0.0001% |
| Murphy-Chutorian Douglas | CEO | 55000 0.5731% | $2.03M | 8 | 60 | <0.0001% |
| Chang William H | 10 percent owner | 965306 10.0589% | $35.58M | 4 | 0 | <0.0001% |
| William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 | 10 percent owner | 412537 4.2988% | $15.21M | 1 | 10 | +268.41% |
| Collins Aidan Matthew | director | 1100 0.0115% | $40,546.00 | 2 | 0 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
SMLR Institutional Investors: Active Positions
| Increased Positions | 75 | +81.52% | 3M | +88.38% |
| Decreased Positions | 40 | -43.48% | 2M | -50.96% |
| New Positions | 45 | New | 2M | New |
| Sold Out Positions | 19 | Sold Out | 2M | Sold Out |
| Total Postitions | 127 | +38.04% | 5M | +37.43% |
SMLR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Morgan Stanley | $24,568.00 | 6.26% | 626,403 | +610,326 | +3,796.27% | 2024-12-31 |
| Capital International Investors | $22,379.00 | 5.71% | 570,610 | +570,610 | New | 2024-12-31 |
| Susquehanna Advisors Group, Inc. | $19,558.00 | 4.99% | 498,675 | +498,675 | New | 2024-12-31 |
| Blackrock, Inc. | $14,606.00 | 3.72% | 372,405 | +5,841 | +1.59% | 2024-12-31 |
| Vanguard Group Inc | $12,011.00 | 3.06% | 306,235 | -5,389 | -1.73% | 2024-12-31 |
| Driehaus Capital Management Llc | $7,352.00 | 1.87% | 187,449 | +187,449 | New | 2024-12-31 |
| Shariaportfolio, Inc. | $6,293.00 | 1.61% | 160,453 | +6,837 | +4.45% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $5,896.00 | 1.5% | 150,327 | -34,955 | -18.87% | 2024-12-31 |
| Geode Capital Management, Llc | $5,507.00 | 1.4% | 140,423 | +4,464 | +3.28% | 2024-12-31 |
| Nuveen Asset Management, Llc | $4,885.00 | 1.25% | 124,548 | +99,482 | +396.88% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.